Graham Rickett

Maraviroc (UK-427,857), a Potent, Orally Bioavailable, and Selective Small-Molecule Inhibitor of Chemokine Receptor CCR5 with Broad-Spectrum Anti-Human Immunodeficiency Virus Type 1 Activity

Patrick Dorr, Mike Westby, Susan Dobbs et al. · Antimicrobial Agents and Chemotherapy · 2005 · 1.1K citations

Medicine, Medicinal Chemistry, Pharmacology +17

HIV-1 proteinase is required for synthesis of pro-viral DNA

C. Baboonian, Angus Dalgleish, Lynne Bountiff et al. · Biochemical and Biophysical Research Communications · 1991 · 48 citations

Life Sciences, Biochemistry, Molecular Biology +14

Molecular cloning and radioligand binding characterization of the chemokine receptor CCR5 from rhesus macaque and human

Carolyn Napier, Harriet Sale, Michael Mosley et al. · Biochemical Pharmacology · 2005 · 47 citations

Life Sciences, Immunology, Molecular Biology +12

Crystallizable HIV-1 protease derived from expression of the viral pol gene in Escherichia coli

Dennis E. Danley, Kieran F. Geoghegan, Kathryn G. Scheld et al. · Biochemical and Biophysical Research Communications · 1989 · 20 citations

Life Sciences, Microbiology, Molecular Biology +15

Chapter 2 CCR5 Pharmacology Methodologies and Associated Applications

Roy Mansfield, Sarah Able, Paul Griffin et al. · Methods in enzymology on CD-ROM/Methods in enzymology · 2009 · 16 citations

Medicine, Medicinal Chemistry, Pharmacology +13